Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Change in Receivables (2018 - 2025)

Historic Change in Receivables for AC Immune (ACIU) over the last 9 years, with Q3 2025 value amounting to $36252.2.

  • AC Immune's Change in Receivables fell 8980.24% to $36252.2 in Q3 2025 from the same period last year, while for Sep 2025 it was $16.7 million, marking a year-over-year increase of 19888.44%. This contributed to the annual value of $16.9 million for FY2024, which is 20125.67% up from last year.
  • As of Q3 2025, AC Immune's Change in Receivables stood at $36252.2, which was down 8980.24% from $485571.9 recorded in Q2 2025.
  • AC Immune's 5-year Change in Receivables high stood at $17.1 million for Q4 2024, and its period low was -$16.7 million during Q4 2023.
  • Its 5-year average for Change in Receivables is -$13292.9, with a median of -$64258.6 in 2021.
  • Within the past 5 years, the most significant YoY rise in AC Immune's Change in Receivables was 427444.12% (2022), while the steepest drop was 617636.18% (2022).
  • Quarter analysis of 5 years shows AC Immune's Change in Receivables stood at -$95436.2 in 2021, then surged by 4274.44% to $4.0 million in 2022, then tumbled by 518.41% to -$16.7 million in 2023, then skyrocketed by 202.74% to $17.1 million in 2024, then crashed by 99.79% to $36252.2 in 2025.
  • Its Change in Receivables was $36252.2 in Q3 2025, compared to $485571.9 in Q2 2025 and -$947637.4 in Q1 2025.